BUY Laurus Labs Ltd — Shivangi Sarda, Motilal Oswal
byShivangi Sarda, Motilal OswalHorizon: NA (inferred Intraday)28 Jul 2026, 9:32 am ISTvia CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
10% Returns In Five Days: This Pharma Stock Hits Record High After Q1 Results
NewsNdtv-Profit·28 Jul · today
Top Gainers & Losers on 27 July: CarTrade Tech, Laurus Labs, Infosys, Atul, TBO Tek, Anant Raj among top gainers
NewsLivemint·27 Jul · today
2 advisors have active swing BUY calls on this stock, all issued in the last 14 days
Advisor consensus · adjacent horizon·28 Jul · today
Laurus Labs shares hit record high after multiple upgrades, but Kotak still sees 33% downside
NewsCnbc-Tv18·27 Jul · yesterday
Laurus Labs shares rally over 4% as Q1FY27 profit jumps 126% on strong CDMO growth
NewsEt-Markets·27 Jul · yesterday
Nifty in oversold territory; pullback to 24,000 possible: Analysts
NewsEt-Markets·27 Jul · yesterday
Laurus Labs Limited has disclosed information regarding a composite scheme of arrangement involving its subsidiaries, Laurus Synthesis Private Limited and Sriam Labs Private Limited. The National Comp
BSE · Company Update·25 Jul · 2d ago
Q1 Results Today Highlights: Tata Consumer con. PAT up 28.4%, ACC PAT declines 61.5%, Shriram Finance, Hindustan Zinc, SBI Life, SBI Cards, Laurus Labs Q1 profit rise
NewsHbl·24 Jul · 3d ago
Laurus Labs Ltd has announced its unaudited financial results for the quarter ended June 30, 2026. The press release is enclosed for information.
BSE · Company Update·24 Jul · 4d ago
Laurus Labs Ltd announced the approval of its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The results were approved at a Board Meeting held on July 24,
BSE · Board Meeting·24 Jul · 4d ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.